Ultragenyx CEO talks the company’s path to profitability in developing drugs for rare diseases
Dr. Emil Kakkis, Ultragenyx founder & CEO, joins ‘Closing Bell Overtime’ to talk drug trials and development, its path to profitability and more.
Similar Posts
Spot bitcoin ETFs swing in first day of trading, but show strong investor interest: CNBC Crypto World
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email CNBC Crypto World features the latest news and daily trading updates from the digital currency markets and provides viewers with a look at what’s ahead with high-profile interviews, explainers, and unique stories from the ever-changing crypto industry. On today’s show, Sylvia Jablonski,…
Three-Stock Lunch: Microsoft, KB Home and Bitcoin
Eva Ados, ER Shares CIO, joins ‘Power Lunch’ to discuss three stocks: Microsoft, KB Home and Bitcoin.
UBS Global Wealth Management is ‘overweight’ on Asia ex-Japan stocks
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Adrian Zuercher of UBS Global Wealth Management says stocks in Asia ex-Japan may be “the only region” that will have positive earnings growth this year. 03:31 Wed, Jun 3 20206:36 AM EDT
SEC’s X page hack ‘not a prank’, was ‘designed to make some money’: Silverado Policy’s Alperovitch
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Dmitri Alperovitch, Silverado Policy executive chairman, joins ‘Fast Money’ to talk about the SEC’s page on ‘X’ being hacked and the implications of the hack on the bitcoin market. 05:03 Tue, Jan 9 20246:10 PM EST
Options traders betting Nike’s post earnings move has some real sole
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Fast Money Mike Khouw, Optimize Advisors president, joins CNBC’s Melissa Lee and the Options Action traders to talk Nike. 01:52 Wed, Sep 27 20236:10 PM EDT
Reid: Ban this sport before boxing
CNBC’s John Harwood asks Harry Reid about his boxing days.
